Auregen BioTherapeutics GmbH

Auregen Biotherapeutics is an innovative startup at the forefront of tissue engineering, dedicated to revolutionizing the treatment of auricular defects. Our laboratories are located in Reutlingen (Germany), where research and development for current and upcoming products is performed. Our current focus is addressing microtia, a rare congenital condition where the external ear is underdeveloped. We are driven by the mission to provide effective, personalized, and long-lasting solutions for individuals affected by this condition. Join us on our journey as we strive to make a tangible difference in the lives of those affected by rare diseases, one ear at a time.